Speaker Profile

Ph.D., Director of Clinical Affairs & Medical Education, Genetic Technologies Ltd

Dr. Spaeth is responsible for the development of clinical content and clinical rationale for GTG products. With a focus on transposing GTG’s cutting-edge approach to disease risk modeling into effortless yet actionable genetic-integrated information for both clinicians and patients, she is a cross-functional team member. She is involved in developing and executing commercial clinical research, pilot studies and managing academic research collaborations. She has wide experience in the high complexity laboratory space from assay development to regulatory oversight of laboratory developed tests in the oncology, infectious disease and inherited disease space. Her postdoctoral training was completed at MD Anderson Cancer Center where she focused on the role of the microenvironment in tumor progression. Erika holds a Ph.D. in Biomedical Sciences from the University of Texas Health Science Center and a B.S. in Molecular Biology from the University of Connecticut.

Wellness & Aging Showcase:
Genetic Technologies Ltd

GTG are pioneers in genetic technologies, decoding the genome and unlocking its value for human health. The company is developing the next generation of integrated predictive genetic testing and assessment tools – empowering physicians and patients to proactively manage health.

Leadership in Personalised Predictive Genetics
GeneType is transforming the conversation from a one-size-fits-all model to personalised, predictive health assessment according to your individual risk. Our team, backed by over 20 years of experience, uniquely combine genetic and clinical risk models to predict risk of chronic diseases before onset.

 Session Abstract – PMWC 2022 Silicon Valley

Track 7, June 29

The PMWC 2022 Wellness & Aging Showcase will provide a 15-minute time slot for selected companies in Wellness and Aging to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from selected companies that build innovative solutions and harness the power of digital health, genomics, and data science with the goal to proactively prevent disease, maintain optimal health, and slow down aging.